Vertellus Specialties Reaches Equity Transfer Agreement

INDIANAPOLIS, Nov. 12, 2010 /PRNewswire via COMTEX/ -- Vertellus Specialties Inc. (the "Company"), a leading specialty chemicals company, announced that it will be the acquirer pursuant to an Equity Transfer Agreement reached on November 5, 2010. Further details are available on the Company's Form 8-K posted on the Company's confidential investor website.

About Vertellus Specialties Inc.

Vertellus is a specialty chemicals company focused on the manufacture of ingredients used in pharmaceuticals, personal care, nutrition, agriculture, and a host of other market areas affected by trends favoring "green" technologies and chemistries. Vertellus is the #1 global producer of pyridine and picolines, specialty pyridine derivatives, DEET, castor oil derivatives and systems and the world's #2 producer of Vitamin B-3 and citrate polymer additives. Vertellus benefits from a technically advanced global manufacturing base and has approximately 700 employees. Vertellus is headquartered in Indianapolis, Indiana. Vertellus is owned by Wind Point Partners, a private equity firm based in Chicago. Wind Point acquired Vertellus in 2007 through Wind Point VI, a $715 million fund. Further information is available at

Contact: David Schwind Vertellus Specialties 317-248-6478 Roland Tomforde Broadgate Consultants 212-232-2222 SOURCE Vertellus Specialties Inc. Copyright (C) 2010 PR Newswire. All rights reserved -0- KEYWORD: Indiana INDUSTRY KEYWORD: CHM SUBJECT CODE: CON